Landsberg Bennett & Dubbaneh’s Edwards Lifesciences EW Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$208K	Buy	+1,854	New	+$212K	0.03%	260
2021 Q1	–	Sell	-15,786	Closed	-$1.44M	–	258
2020 Q4	$1.44M	Sell	15,786 -811	-5%	-$67.3K	0.22%	103
2020 Q3	$1.3M	Buy	16,597 +6,091	+58%	+$475K	0.23%	101
2020 Q2	$713K	Buy	+10,506	New	+$747K	0.15%	122
2020 Q1	–	Sell	-7,869	Closed	-$610K	–	173
2019 Q4	$610K	Buy	+7,869	New	+$614K	0.14%	133

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's EW Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh opened a new position in Edwards Lifesciences (EW) in Q3 2021: 1,854 shares worth $208K. The stake represents 0.03% of the portfolio and ranks #260 among its holdings. This is a return to the name: Landsberg Bennett & Dubbaneh previously reported a position in EW as recently as Q4 2020.

Landsberg Bennett & Dubbaneh first reported a position in EW in Q4 2019 and has held it in 5 quarters since. The position peaked at $1.44M in Q4 2020. 1,228 funds tracked by Wall St. Rank hold EW as of Q3 2021.

Landsberg Bennett & Dubbaneh held 1,854 shares of Edwards Lifesciences worth $208K as of Q3 2021.
Edwards Lifesciences was a new Landsberg Bennett & Dubbaneh position in Q3 2021.
Edwards Lifesciences made up 0.03% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #260 holding.
Landsberg Bennett & Dubbaneh first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 5 quarters since.
Landsberg Bennett & Dubbaneh's Edwards Lifesciences position peaked at $1.44M in Q4 2020.
1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.